HP&M Attorney to Speak at CBI Paragraph IV Disputes Conference

October 5, 2010

Hyman, Phelps & McNamara, P.C.’s Kurt R. Karst will be speaking at the Center for Business Intelligence’s (“CBI’s”) 3rd Annual Life Sciences Congress on Paragraph IV Disputes, which is scheduled for October 18-19, 20109 at the Hilton Alexandria Old Town in Alexandria, Virginia.  This popular CBI conference brings together representatives from both the brand-name and generic drug industries to discuss litigation strategies, statutory guidelines, current cases, and their landmark decisions.  A copy of the conference brochure is available here.  In addition to presenting a session on the FDC Act’s 180-day exclusivity forfeiture provisions, Mr. Karst, along with Sean Ryder (Glenmark), and Joe Bonaccorsi (Akorn), will put on a “Paragraph IV Boot Camp” workshop on myriad Paragraph IV issues. 

Special FDA Law Blog Discount – CBI is offering FDA Law Blog readers a $300 discount off of the registration fee.  To register for the conference, go to the CBI website and enter the following promotion code: ZUE255


Categories: Hatch-Waxman |  Miscellaneous